Acute headache treatments in patients with health care coverage: What prescriptions are doctors writing?

Headache and Pain: Diagnostic Challenges, Current Therapy

Volumn 17, Issue 1, 2006, Pages 11-17

  Tepper, Stewart J ^a,b   Martin, Vincent ^c   Burch, Steven P ^d   Fu, Alex Z ^e   Kwong, W Jacqueline ^f   Downs, Kristen E ^g  

^a NEW ENGLAND CENTER FOR HEADACHE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d GLAXOSMITHKLINE   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

^f UNIVERSITY OF GEORGIA   (United States)

^g Relevant Health Outcomes Inc   (United States)

Author keywords

Analgesics; Headache; Migrate; Narcotics; Opioids; Triptans

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ATORVASTATIN; AZITHROMYCIN; CEFALEXIN; CYCLOOXYGENASE 2 INHIBITOR; ERGOT ALKALOID; FEXOFENADINE; FLUTICASONE; LEVOFLOXACIN; NARCOTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PREDNISONE; SALBUTAMOL;

COHORT ANALYSIS; DATA BASE; DIAGNOSTIC ERROR; EDUCATION; EMERGENCY WARD; HEADACHE; HEALTH CARE SYSTEM; HEALTH INSURANCE; HUMAN; MIGRAINE; PRESCRIPTION; PRIORITY JOURNAL; PRODUCTIVITY; REPETITIVE STRAIN INJURY; REVIEW; WRITING;

EID: 33745946507     PISSN: 15458261     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Lipton RB, Stewart WF, Diamond S, et al. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache. 2001;41:646-657.
2. Lipton RB, Stewart WF, Reed M, et al. Migraine diagnosis and treatment: results from the American Migraine Study II. Headache. 2001;41:638-645.
3. Burton WN, Conti DJ, Chen CY, et al. The economic burden of lost productivity due to migraine headache: a specific worksite analysis. J Occup Environ Med. 2002;44:523-529.
4. Stang PE, Osterhaus JT. Impact of migraine in the United States: data from the National Health Interview Survey. Headache. 1993;33:29-35.
5. Stewart WF, Lipton RB, Celentano DD, Reed M. Prevalence of migraine headache in the United States: relation to age, income, race, and other sociodemographic factors. JAMA. 1992;267:64-69.
6. Silberstein SD, Olesen J, Bousser MG, et al. The international classification of headache disorders, 2nd edition (ICHD-II)-revision of criteria for 8.2 medication-overuse headache. Cephalalgia. 2005;25:460-465.
7. Bigal ME, Rapoport AM, Sheftell FD, et al. Transformed migraine and medication overuse in a tertiary headache centre-clinical characteristics and treatment outcomes. Cephalalgia. 2004;24:483-490.
8. Bahra A, Walsh M, Menon S, Goadsby PH. Does chronic daily headache arise de novo in association with regular use of analgesics? Headache. 2203;43:179-190.
9. Mathew NE, Stubits E, Nigam MP. Transformation of episodic migraine into daily headache: analysis of factors. Headache. 1982;22:66-68.
10. Wolfe MM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs. N Engl J Med. 1999; 340:1888-1899.
11. Williams DR, Stark RJ. Intravenous lignocaine (lidocaine) infusion for the treatment of chronic daily headache with substantial medication overuse. Cephalalgia. 2003;23:963-971.
12. Wilkinson SM, Becker WJ, Heine JA. Opiate use to control bowel motility may induce chronic daily headache in patients with migraine. Headache. 2001;41:303-309.
13. Ziegler DK. Opioids in headache treatment. Is there a role? Neurol Clin. 1997;15:199-207.
14. IHCIS Healthcare Information Solutions. Available at: www.ihcis.com/Default.asp? Flash=true. Accessed October 5, 2005.
15. Tepper SJ, Kwong WJ, Krengel PZ. Narcotic use among headache sufferers with health insurance coverage. Poster presentation at the 2004 Headache Update, Orlando, Fla.
16. Lipton RB, Stewart WF, Stone AM, et al. Stratified care versus step care strategies for migraine: the Disability in Strategies of Care (DISC) Study: a randomized trial. JAMA. 2000;284:2599-2605.
17. Lambert J, Carides GW, Meloche JP, et al. Impact of migraine symptoms on health care use and work loss in Canada in patients randomly assigned in a phase III clinical trial. Can J Clin Pharmacol. 2002;9:158-164.
18. Pransky GS, Berndt E, Finkelstein SN, et al. Performance decrements resulting from illness in the workplace: the effect of headaches. J Occup Environ Med. 2005;47:34-40.
19. Weaver MB, Mackowiak JI, Solari PG. Triptan therapy impacts health and productivity. J Occup Environ Med. 2004;46:812-817.
20. Lainez MJ, Lopez A, Pascual AM. Effects on productivity and quality of life of rizatriptan for acute migraine: a workplace study. Headache. 2005;45:883-890.
21. Tepper SJ. Debate: analgesic overuse is a cause, not consequence, of chronic daily headache. Analgesic overuse is a cause of chronic daily headache. Headache. 2002;42:543-547.
22. Isler H. Migraine treatment as a cause of chronic migraine. In: Rose FC, ed. Advances in Migraine Research and Therapy. New York: Raven Press; 1982:159-164.
23. Lafata JE, Moon C, Leotta C, et al. The medical care utilization and costs associated with migraine headache. J Gen Intern Med. 2004;19:1005-1012.